MENU
ABBV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ABBVIE (ABBV) Ownership - Who owns ABBVIE?

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

Profile

Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
57000
Web
https://www.abbvie.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
466.45B
P/E Ratio
74.56
Total Cash
6.57B
Projected Growth
0.54
Total Debt
70.82B
Revenue
64.39B
Risk (Beta)
0.03
Dividend Yield
0.03
Total Cash/Share
3.72
Total Debt/Equity
314.07
Revenue/Share
36.30 USD as % of share price
View a ticker or compare two or three
ABBV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
57000
Web
https://www.abbvie.com
Who owns ABBVIE? ABBV symbol Ownership - Tickeron.com